-
Abstract: Neuroendocrine carcinoma(NEC) of the tonsil is extremely rare that exhibits highly malignant and poorly prognosis. Only a few of case reports and the optial treatment is still uncertain. Here, the current study presents a case of 60-year-old male with neck mass rapidly growing for four months. It was diagnosed a primary tonsil neuroendocrine carcinoma. And he was treated by one cycle of cisplatin and etoposide. It had no effect and the tumor was rapidly progressed. With review of the literatures, the nomenclature, clinicopathological characteristics and treatment modalities of this rare tumor are discussed.
-
Key words:
- neuroendocrine carcinoma /
- small cell carcinoma /
- tonsil /
- immunohistochemistry
-
-
[1] OSAZUWA-PETERS N, SIMPSON M C, MASSA S T, et al.40-year incidence trends for oropharyngeal squamous cell carcinoma in the United States[J].Oral Oncol, 2017, 74:90-97.
[2] RIGHI L, GATTI G, VOLANTE M, et al.Lung neuroendocrine tumors:pathological characteristics[J].J Thorac Dis, 2017, 9:S1442-s1447.
[3] SIPOS B.Neuroendocrine neoplasms of the auditory, olfactory, and visual sensory organs[J].Der Pathol, 2018, 39:255-263.
[4] YUAN Y, ZOU Q F, HU X Y, et al.Tonsil neuroendocrine carcinoma concurrent with hepatocellular carcinoma:a case report[J].Oncol Lett, 2014, 8:1035-1036.
[5] NAKAHIRA M, KUBA K, MATSUMURA S, et al.Primary small cell carcinoma of the hypopharynx:a report of two cases and review of nine additional cases[J].Case Report Otolaryngol, 2017, 2017:8143145-8143145.
[6] FAISAL M, HAIDER I, ADEEL M, et al.Small cell neuroendocrine carcinoma of nose and paranasal sinuses:the shaukat khanum memorial cancer hospital experience and review of literature[J].J Pak Med Asso, 2018, 68:133-136.
[7] 徐建慧, 叶飞, 陈嵘, 等.鼻腔鼻窦小细胞神经内分泌癌2例[J].临床耳鼻咽喉头颈外科杂志, 2016, 30(7):579-580.
[8] GALE N, POLJAK M, ZIDAR N.Update from the4th Edition of the World Health Organization Classification of Head and Neck Tumours:What is new in the 2017 WHO blue book for tumours of the hypopharynx, larynx, trachea and parapharyngeal space[J].Head Neck Pathol, 2017, 11:23-32.
[9] SCOAZEC J Y, COUVELARD A, TENPATH R.Classification of pancreatic neuroendocrine tumours:Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future[J].Ann Pathol, 2017, 24:179-181.
[10] LEWIS J S, CHERNOCK R D, BISHOP J A.Squamous and neuroendocrine specific immunohistochemical markers in head and neck squamous cell carcinoma:a tissue microarray study[J].Head Neck Pathol, 2017, 13:1-9.
[11] 林海容, 徐澍, 龚正鹏.耳鼻咽喉神经内分泌癌临床分析[J].临床耳鼻咽喉头颈外科杂志, 2016, 30(10):828-831.
[12] 赵春丽, 路承, 张奥博, 等.扁桃体原发神经内分泌癌2例[J].临床耳鼻咽喉头颈外科杂志, 2016, 30(23):1904-1906.
[13] 林晓琳, 许琦, 刘泽兵, 等.胃神经内分泌癌临床病理特征及预后相关因素[J].肿瘤, 2017, 37(10):1079-1085.
[14] SEHGAL I S, KAUR H, DHOORIA S, et al.Extrapulmonary small cell carcinoma of lymph node:Pooled analysis of all reported cases[J].World J Clin Oncol, 2016, 7:308-310.
[15] MISAWA K, KAWASAKI H, MATSUO R, et al.Human papillomavirus-associated small cell carcinoma/neuroendocrine carcinoma of the oropharynx:a report of two cases[J].Springerplus, 2016, 5:1847-1849.
[16] BLESL A, KRONES E, POLLHEIMER M J, et al.Downgrading of a G3neuroendocrine tumor to a G2Tumor:can first-line cytotoxic chemotherapy change the tumor biology[J]?Oncology, 2017, 10:1121-1126.
[17] RINKE A, GRESS T M.Neuroendocrine cancer, therapeutic strategies in G3cancers[J].Digestion, 2017, 95:109-114.
[18] BERG K.Medical therapy of gastrointestinal neuroendocrine tumors[J].Visc Med, 2017, 12:352-356.
[19] FAIVRE S, NICCOLI P, CASTELLANO D, et al.sunitinib in pancreatic neuroendocrine tumors:updated progression-free survival and final overall survival from a phase iii randomized study[J].Ann Oncol, 2016, 28:561-567.
-
计量
- 文章访问数: 209
- PDF下载数: 104
- 施引文献: 0
下载: